New Risk • Apr 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Announcement • Mar 30
Suzhou Nanomicro Technology Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Suzhou Nanomicro Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Reported Earnings • Mar 02
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: CN¥0.34 (up from CN¥0.21 in FY 2024). Revenue: CN¥924.7m (up 18% from FY 2024). Net income: CN¥136.0m (up 64% from FY 2024). Profit margin: 15% (up from 11% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 3.4%. Earnings per share (EPS) also missed analyst estimates by 7.0%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 20% per year. Announcement • Dec 26
Suzhou Nanomicro Technology Co., Ltd. to Report Fiscal Year 2025 Results on Mar 26, 2026 Suzhou Nanomicro Technology Co., Ltd. announced that they will report fiscal year 2025 results on Mar 26, 2026 Reported Earnings • Oct 29
Third quarter 2025 earnings released: EPS: CN¥0.11 (vs CN¥0.008 loss in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.11 (up from CN¥0.008 loss in 3Q 2024). Revenue: CN¥257.1m (up 23% from 3Q 2024). Net income: CN¥44.5m (up CN¥47.5m from 3Q 2024). Profit margin: 17% (up from net loss in 3Q 2024). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Announcement • Sep 30
Suzhou Nanomicro Technology Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025 Suzhou Nanomicro Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025 Announcement • Jun 30
Suzhou Nanomicro Technology Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025 Suzhou Nanomicro Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025 Declared Dividend • Jun 11
Dividend increased to CN¥0.063 Dividend of CN¥0.063 is 26% higher than last year. Ex-date: 13th June 2025 Payment date: 13th June 2025 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (27% earnings payout ratio) and cash flows (65% cash payout ratio). The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 161% over the next 3 years, which should provide support to the dividend and adequate earnings cover. New Risk • May 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Apr 25
First quarter 2025 earnings released: EPS: CN¥0.073 (vs CN¥0.042 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.073 (up from CN¥0.042 in 1Q 2024). Revenue: CN¥188.6m (up 22% from 1Q 2024). Net income: CN¥29.2m (up 73% from 1Q 2024). Profit margin: 16% (up from 11% in 1Q 2024). Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings. Announcement • Apr 25
Suzhou Nanomicro Technology Co., Ltd., Annual General Meeting, May 15, 2025 Suzhou Nanomicro Technology Co., Ltd., Annual General Meeting, May 15, 2025, at 14:00 China Standard Time. Location: R and D Center Building, No. 2, Baichuan Street, Suzhou Industrial Park, Suzhou, Jiangsu China New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.2% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change). Announcement • Mar 28
Suzhou Nanomicro Technology Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025 Suzhou Nanomicro Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025 Reported Earnings • Feb 27
Full year 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.17 in FY 2023) Full year 2024 results: EPS: CN¥0.20 (up from CN¥0.17 in FY 2023). Revenue: CN¥782.6m (up 33% from FY 2023). Net income: CN¥81.1m (up 18% from FY 2023). Profit margin: 10% (down from 12% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 34% per year, which means it has not declined as severely as earnings. New Risk • Jan 12
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company. Announcement • Dec 27
Suzhou Nanomicro Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 30, 2025 Suzhou Nanomicro Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 30, 2025 Reported Earnings • Oct 30
Third quarter 2024 earnings released: CN¥0.008 loss per share (vs CN¥0.018 profit in 3Q 2023) Third quarter 2024 results: CN¥0.008 loss per share (down from CN¥0.018 profit in 3Q 2023). Revenue: CN¥210.0m (up 35% from 3Q 2023). Net loss: CN¥3.05m (down 143% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 38% per year whereas the company’s share price has fallen by 35% per year. New Risk • Sep 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.6% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (13% net profit margin). Announcement • Sep 30
Suzhou Nanomicro Technology Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Suzhou Nanomicro Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 New Risk • Sep 15
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (13% net profit margin). Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.048 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.07 (up from CN¥0.048 in 2Q 2023). Revenue: CN¥185.7m (up 14% from 2Q 2023). Net income: CN¥28.2m (up 45% from 2Q 2023). Profit margin: 15% (up from 12% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 47% per year, which means it is performing significantly worse than earnings. Announcement • Jun 29
Suzhou Nanomicro Technology Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Suzhou Nanomicro Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Announcement • Apr 26
Suzhou Nanomicro Technology Co., Ltd., Annual General Meeting, May 15, 2024 Suzhou Nanomicro Technology Co., Ltd., Annual General Meeting, May 15, 2024, at 14:30 China Standard Time. Location: Comprehensive Building, No. 2, Baichuan Street, Suzhou Industrial Park, Suzhou, Jiangsu China Reported Earnings • Apr 25
First quarter 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.031 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.042 (up from CN¥0.031 in 1Q 2023). Revenue: CN¥154.1m (up 17% from 1Q 2023). Net income: CN¥16.9m (up 37% from 1Q 2023). Profit margin: 11% (up from 9.4% in 1Q 2023). Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Announcement • Mar 30
Suzhou Nanomicro Technology Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024 Suzhou Nanomicro Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 25, 2024 Reported Earnings • Feb 29
Full year 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.69 in FY 2022) Full year 2023 results: EPS: CN¥0.17 (down from CN¥0.69 in FY 2022). Revenue: CN¥586.6m (down 17% from FY 2022). Net income: CN¥69.2m (down 75% from FY 2022). Profit margin: 12% (down from 39% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Announcement • Feb 01
Suzhou Nanomicro Technology Co., Ltd. (SHSE:688690) announces an Equity Buyback for CNY 100 million worth of its shares. Suzhou Nanomicro Technology Co., Ltd. (SHSE:688690) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its A shares. The shares will be purchased at a price not exceeding CNY 35 per share. The purpose of the program is to improving quality, increasing efficiency and focusing on returns. The repurchased shares will be used for employee stock ownership plans or equity incentive plans, otherwise will be cancelled if the company fails to transfer them within the time limit stipulated by relevant laws and regulations. The program will be valid for 12 months. Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.018 (vs CN¥0.12 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.018 (down from CN¥0.12 in 3Q 2022). Revenue: CN¥156.0m (down 12% from 3Q 2022). Net income: CN¥7.16m (down 85% from 3Q 2022). Profit margin: 4.6% (down from 27% in 3Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.048 (vs CN¥0.26 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.048 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥163.0m (up 6.6% from 2Q 2022). Net income: CN¥19.5m (down 81% from 2Q 2022). Profit margin: 12% (down from 68% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 35% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Reported Earnings • Apr 26
First quarter 2023 earnings released: EPS: CN¥0.031 (vs CN¥0.15 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.031 (down from CN¥0.15 in 1Q 2022). Revenue: CN¥132.1m (down 6.2% from 1Q 2022). Net income: CN¥12.4m (down 80% from 1Q 2022). Profit margin: 9.4% (down from 43% in 1Q 2022). The decrease in margin was primarily driven by higher expenses. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.13 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.12 (down from CN¥0.13 in 3Q 2021). Revenue: CN¥176.4m (up 51% from 3Q 2021). Net income: CN¥46.9m (down 6.6% from 3Q 2021). Profit margin: 27% (down from 43% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 41% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Oct 12
Investor sentiment deteriorated over the past week After last week's 22% share price decline to CN¥55.40, the stock trades at a forward P/E ratio of 60x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 27% over the past year. Reported Earnings • Aug 15
Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.12 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.26 (up from CN¥0.12 in 2Q 2021). Revenue: CN¥153.0m (up 54% from 2Q 2021). Net income: CN¥104.1m (up 142% from 2Q 2021). Profit margin: 68% (up from 43% in 2Q 2021). The increase in margin was primarily driven by higher revenue. Over the next year, revenue is forecast to grow 52%, compared to a 41% growth forecast for the Chemicals industry in China. Reported Earnings • Apr 27
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: CN¥0.15 (up from CN¥0.062 in 1Q 2021). Revenue: CN¥140.9m (up 112% from 1Q 2021). Net income: CN¥60.9m (up 176% from 1Q 2021). Profit margin: 43% (up from 33% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 22%. Earnings per share (EPS) also surpassed analyst estimates by 33%. Over the next year, revenue is forecast to grow 48%, compared to a 43% growth forecast for the industry in China. Announcement • Apr 13
Suzhou Nanomicro Technology Co., Ltd. (SHSE:688690) agreed to acquire 43.9621% stake in Suzhou Sepure Instruments Inc from Suzhou Niudemin Technology Consulting Co., Ltd., Wujiang Haibo Technology Venture Capital Co., Ltd., Suzhou Puchun Management Consulting Partnership Enterprise (Limited Partnership), Nie Honglin, Xu Juanjuan, Suzhou Haidatong Technology Venture Capital Co., Ltd., Cen Yundong, Zhang Bin and Zhang Zhijuan for approximately CNY 113 million. Suzhou Nanomicro Technology Co., Ltd. (SHSE:688690) agreed to acquire 43.9621% stake in Suzhou Sepure Instruments Inc from Suzhou Niudemin Technology Consulting Co., Ltd., Wujiang Haibo Technology Venture Capital Co., Ltd., Suzhou Puchun Management Consulting Partnership Enterprise (Limited Partnership), Nie Honglin, Xu Juanjuan, Suzhou Haidatong Technology Venture Capital Co., Ltd., Cen Yundong, Zhang Bin and Zhang Zhijuan for approximately CNY 113 million on April 8, 2022. As on December 31, 2022, Suzhou Sepure Instruments Inc has total assets of CNY 46,266,900?, Revenue of CNY 84,675,100?, and net profit of CNY 20,711,800. Suzhou Nanomicro Technology Co., Ltd's board of directors approved the transaction. Reported Earnings • Feb 28
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥0.50 (up from CN¥0.20 in FY 2020). Revenue: CN¥446.3m (up 118% from FY 2020). Net income: CN¥188.1m (up 159% from FY 2020). Profit margin: 42% (up from 36% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 22%. Earnings per share (EPS) also surpassed analyst estimates by 33%. Over the next year, revenue is forecast to grow 30%, compared to a 47% growth forecast for the industry in China.